| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.04 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.098 | 0.04 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.14 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.04 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.05 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |